Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
doi:10.1056/NEJMp1314078
181 TardatM.DjardinJ
Orange Book listings of questionable eligibility create regulatory and litigation exposure that diligence must flag
Myth 3: "If it's still blue, it's still good." As we mentioned earlier, this is a dangerous assumption
Advances in artificial intelligence and machine learning might soon offer predictive insights and individualized recommendations, allowing patients to take a more active role in their health
Back Day, JW, Ottaway, N, Patterson, JT, et al (13 July 2009) 'A new glucagon and GLP-1 co-agonist eliminates obesity in rodents', Nature Chemical Biology
US$ 27.02
US$ 27.10
US$ 26.35
US$ 27.82
US$ 27.77
US$ 23.92
US$ 26.61
US$ 20.73
US$ 25.79
US$ 26.44
US$ 24.35
